Articles with the topic: featured

Highlighting a link between brain disorders on Ataxia Awareness Day

Highlighting a link between brain disorders on Ataxia Awareness Day

September 25th is Ataxia Awareness Day, so HDBuzz is highlighting the connections between HD and Ataxia research. Learn about how these fields have historically grown in parallel and informed one another.

Dr Leora FoxSeptember 25, 2024

Hope vs. hype: seeking truth in recent Prilenia headlines

Hope vs. hype: seeking truth in recent Prilenia headlines

Although pridopidine has suffered four negative trials for HD, the message from Prilenia continues to be positive. What is hope and what is hype in this sixteen-year quest for regulatory approval?

Dr Sarah HernandezSeptember 10, 2024

Mini brains grown in a dish shed light on Huntington’s disease and how we might treat it

Mini brains grown in a dish shed light on Huntington’s disease and how we might treat it

Exciting new findings using 3D human lab-grown mini brains inform ongoing HTT-lowering trials and suggest that stem cell transplants for HD may improve cell-to-cell communication and reduce disease features.

Dr Sarah HernandezAugust 23, 2024

Hereditary Disease Foundation (HDF) conference 2024 – Day 4

Hereditary Disease Foundation (HDF) conference 2024 – Day 4

Read our live tweet compilation from clinical trials and scientific research on Huntington’s disease from Day 4 of the 2024 HDF Milton Wexler Biennial Symposium #HD2024

Dr Sarah Hernandez and Dr Rachel HardingAugust 13, 2024

Hereditary Disease Foundation (HDF) conference 2024 – Day 3

Hereditary Disease Foundation (HDF) conference 2024 – Day 3

Read our live tweet compilation from clinical trials and scientific research on Huntington’s disease from Day 3 of the 2024 HDF Milton Wexler Biennial Symposium #HDF2024

Dr Rachel Harding and Dr Sarah HernandezAugust 12, 2024

Hereditary Disease Foundation (HDF) conference 2024 – Day 2

Hereditary Disease Foundation (HDF) conference 2024 – Day 2

Read updates from clinical trials and scientific research on Huntington’s disease from Day 2 of the 2024 HDF Milton Wexler Biennial Symposium #HDF2024

Dr Tamara Maiuri, Dr Sarah Hernandez, and Dr Rachel HardingAugust 10, 2024

Hereditary Disease Foundation (HDF) conference 2024 – Day 1

Hereditary Disease Foundation (HDF) conference 2024 – Day 1

Read updates from clinical trials and scientific research on Huntington’s disease from Day 1 of the 2024 HDF Milton Wexler Biennial Symposium #HDF2024

Dr Rachel Harding, Dr Tamara Maiuri, and Dr Sarah HernandezAugust 09, 2024

Blue skies for Skyhawk: Positive news from Phase 1 trial for SKY-0515

Blue skies for Skyhawk: Positive news from Phase 1 trial for SKY-0515

There’s more good news in the forecast in the Huntington’s disease therapeutic space as we receive positive results from Skyhawk Therapeutics about their small molecule SKY-0515 that lowers huntingtin and targets somatic expansion.

Dr Sarah HernandezJuly 11, 2024

Positive news from Wave Life Sciences SELECT-HD trial

Positive news from Wave Life Sciences SELECT-HD trial

The outcomes of the SELECT-HD clinical trial are out, with encouraging news for this allele-selective huntingtin lowering therapy

Dr Rachel HardingJune 28, 2024

Donate

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community.

With your support, we can ensure the continuity of our services. Nothing is expected, but everything is appreciated and sustains what we do at HDBuzz. Please consider giving what you're able. More information...